Related Experiment Video
Updated: Apr 7, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women
B Siegerink1,2,3, A Maino1,4, A Algra1,5,6
1Department Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Insights
Prothrombotic factors, indicators of hypercoagulability, are more strongly linked to ischemic stroke (IS) risk than myocardial infarction (MI) risk in young women. This suggests distinct hypercoagulability roles in the development of these arterial thrombotic events.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Thrombosis Research
Background:
- Myocardial infarction (MI) and ischemic stroke (IS) are acute arterial thrombotic events with partially overlapping risk factors.
- Distinct pathophysiological mechanisms underlie MI and IS, necessitating investigation into differential risk factor associations.
Purpose of the Study:
- To investigate whether hypercoagulability differentially impacts the risk of MI versus IS.
- To identify specific prothrombotic factors associated with increased risk for either MI or IS.
Main Methods:
- Analysis of a population-based case-control study (Risk of Arterial Thrombosis in Relation to Oral Contraceptives) involving young women (<50 years).
- Comparison of relative odds ratios (ORIS/ORMI) and confidence intervals for 29 identified prothrombotic factors in women with MI, non-cardioembolic IS, and healthy controls.
Main Results:
- Seventy-two percent (21/29) of hypercoagulability measures showed increased odds ratios for arterial thrombosis.
- Twelve factors (41%) demonstrated odds ratios greater than 2, and five factors (17%) exceeded 2.75.
- Activated factor XI (FXI) and FXII, kallikrein, lupus anticoagulans, and FXIII gene variation showed the most significant differential associations.
Conclusions:
- Prothrombotic factors are more strongly associated with ischemic stroke risk than myocardial infarction risk in young women.
- These findings suggest a differential role of hypercoagulability in the pathogenesis of IS compared to MI.
Background:
Myocardial infarction (MI) and ischemic stroke (IS) are acute forms of arterial thrombosis and share some, but not all, risk factors, indicating different pathophysiological mechanisms.
Objective:
This study aims to determine if hypercoagulability has a differential effect on the risk of MI and IS.
Patients And Methods:
We reviewed the results from the Risk of Arterial Thrombosis in Relation to Oral Contraceptives study, a population-based case-control study involving young women (< 50 years) with MI, non-cardioembolic IS and healthy controls. From these data, relative odds ratios (ORIS /ORMI ) and their corresponding confidence intervals for all prothrombotic factors that were studied in both subgroups were calculated.
Results:
Twenty-nine prothrombotic risk factors were identified as measures of hypercoagulability. Twenty-two of these risk factors (21/29, 72%) had a relative odds ratios > 1; for 12 (41%), it was > 2; and for 5 (17%), it was > 2.75. The five risk factors with the largest differences in associations were high levels of activated factor XI (FXI) and FXII, kallikrein, the presence of lupus anticoagulans, and a genetic variation in the FXIII gene.
Conclusion:
In young women, prothrombotic factors are associated more with the risk of IS than with MI risk, suggesting a different role of hypercoagulability in the mechanism leading to these two diseases.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
